Page 4 - Nanoform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nanoform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nanoform Today - Breaking & Trending Today

Nanoform Finland Oyj : Interim Report January – September 2021

Company Announcement

Nanoform Finland Plc

November 25, 2021

08:10 a.m. Finnish time / 07:10 a.m. Swedish time

Nanoform Interim. | November 25, 2021 ....

United States , United Kingdom , Eteläuomen Läi , San Diego , Celanese Vitaldose , Christian Jones , Nathalie Huther , Miguel Calado , Biologics Po , Jeanne Thoma , Christopher Worral , Vp Business Development Europe , Finnish Financial Supervisory Authority , Boehringer Ingelheim , Melinda Gates Foundation , Finland Branch , Data Business Solutions , Danske Bank , Celanese Corporation , Nanoform Finland Plc , Herantis Pharma Plc , Company Announcement , Master Services Agreement , Vp Business Development , European Biotech Company , Nacuity Pharmaceuticals ,

Nanoform Finland Oyj : Notice to the Extraordinary General Meeting of NANOFORM FINLAND PLC

Company Announcement

Nanoform Finland Plc

October 18, 2021

08:10 a.m. Finnish time / 07:10 a.m. Swedish time

Notice to the extraordinary General Meeting of NANOFORM FINLAND PLC

The shareholders. | October 18, 2021 ....

Eteläuomen Läi , Miguel Calado , Marko Vuori , Jeanne Thoma , Technologies Association , Finnish Limited Liability Companies , Vectura Group , Finland Branch , Euroclear Finland Ltd , Avid Bioservices Inc , Danske Bank , Nanoform Finland Plc , Pharma Inc , Pharmaceuticals Inc , Company Announcement , General Meeting , Finland Plc , Extraordinary General Meeting , Finnish Limited Liability Companies Act , Board Members , Non Executive Director , Bioservices Inc , Associated Technologies Association , Microbial Control , Chief Human Resource Officer , Extraordinary General ,

Nanoform Interim Report January

/PRNewswire/ The strong momentum continues: Additional line capacity, more projects, new clients, the number of employees crosses 100, while the gross. ....

Eteläuomen Läi , San Diego , United States , United Kingdom , Celanese Vitaldose , Christian Jones , Chris Worral , Miguel Calado , Biologics Po , Master Services Agreement , Vp Business Development , Boehringer Ingelheim , European Biotech Company , Nacuity Pharmaceuticals , Finland Branch , Danske Bank , Coast Us Biotech Company , Celanese Corporation , Herantis Pharma Plc , Biologics Proof , Concept Agreement , Biologics Poc , East Coast , Commercial Insights Officer , Oxford United Kingdom , European Biotech ,

Nanoform, Aprecia partner on 3D-printed nanomedicines

The two companies plan to collaboratively explore ways to combine 3D printing and nanotechnology, in order to create nanoparticle-enabled dosage forms. ....

Chris Gilmore , Nanoform Finland , Contract Manufacturing Amp Logistics , Drug Delivery , Clinical Development , Atient Centricity , Linical Evolution , Delivery Formulations , Delivery Technologies , Hasei Ii , Phase Iii Iv , Clinical Trials , கிறிஸ் கில்மோர் , ஒப்பந்த உற்பத்தி ஆம்ப் தளவாடங்கள் ,

Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines

Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines
News provided by
Share this article
Share this article
HELSINKI, April 21, 2021 /PRNewswire/ Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Aprecia, the 3DP (three-dimensional printing) pharmaceutical company, announce that they are exploring the synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms. This collaboration seeks to provide customers and the pharmaceutical industry with new capabilities in patient centric therapies.
The immediate product innovation target for the collaboration is to combine Nanoform s fast dissolution nanoformed particles with Aprecia s ZipDose
(TM) technology platform for rapid disintegration to enable high performance buccal and oral delivery of medicines to patients where rapid absorption is essential. Additional benefits may include lower dosage products, less excipient co ....

Eteläuomen Läi , Chris Gilmore , Aprecia Zipdose , Christian Joneschief , Don Wetherhold , Danske Bank , Technology Platform , Finnish Financial Supervisory Authority , Nanoform Finland Plc , Finland Branch , Nasdaq First North Growth Market , Certified Adviser , Looking Statements , கிறிஸ் கில்மோர் , தொழில்நுட்பம் நடைமேடை , பின்னிஷ் நிதி மேற்பார்வை அதிகாரம் , பின்லாந்து கிளை , நாஸ்டாக் முதல் வடக்கு வளர்ச்சி சந்தை , பார்க்கிறது அறிக்கைகள் ,